- Home
- AXSM vs BLKB Comparison
AXSM vs BLKB Comparison
Compare AXSM & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- BLKB
- Stock Information
- Founded
- AXSM 2012
- BLKB 1981
- Country
- AXSM United States
- BLKB United States
- Employees
- AXSM N/A
- BLKB N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- BLKB Computer Software: Prepackaged Software
- Sector
- AXSM Health Care
- BLKB Technology
- Exchange
- AXSM Nasdaq
- BLKB Nasdaq
- Market Cap
- AXSM 4.2B
- BLKB 3.8B
- IPO Year
- AXSM 2015
- BLKB 2004
- Fundamental
- Price
- AXSM $84.60
- BLKB $75.10
- Analyst Decision
- AXSM Strong Buy
- BLKB Hold
- Analyst Count
- AXSM 14
- BLKB 3
- Target Price
- AXSM $125.54
- BLKB $86.67
- AVG Volume (30 Days)
- AXSM 893.5K
- BLKB 185.2K
- Earning Date
- AXSM 02-18-2025
- BLKB 02-10-2025
- Dividend Yield
- AXSM N/A
- BLKB N/A
- EPS Growth
- AXSM N/A
- BLKB N/A
- EPS
- AXSM N/A
- BLKB 0.99
- Revenue
- AXSM $338,457,000.00
- BLKB $1,148,274,000.00
- Revenue This Year
- AXSM $44.77
- BLKB $6.75
- Revenue Next Year
- AXSM $67.70
- BLKB $5.76
- P/E Ratio
- AXSM N/A
- BLKB $76.64
- Revenue Growth
- AXSM 51.47
- BLKB 5.81
- 52 Week Low
- AXSM $64.11
- BLKB $66.47
- 52 Week High
- AXSM $105.00
- BLKB $88.95
- Technical
- Relative Strength Index (RSI)
- AXSM 43.66
- BLKB 40.39
- Support Level
- AXSM $79.19
- BLKB $73.74
- Resistance Level
- AXSM $87.53
- BLKB $75.47
- Average True Range (ATR)
- AXSM 4.37
- BLKB 1.23
- MACD
- AXSM -0.02
- BLKB 0.25
- Stochastic Oscillator
- AXSM 61.27
- BLKB 58.43
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.